Close to a dozen cultivated meat products now hold regulatory clearance somewhere in the world. None of them is being sold at anything resembling commercial scale. That gap — approvals accumulating while volumes do not — is the real story of cultivated meat in 2026, and it is a very different story from the one the sector was telling five years ago.
Canada sits on the outside of it, with submissions filed at Health Canada under the novel foods framework and no published decision. Understanding why requires looking at what approval actually buys a company.
Who has approved what
The approvals are concentrated in five jurisdictions, and they are not equivalent. Some cover a single product from a single company at a single facility. Others are broader.
| Jurisdiction | Status | Products cleared | Notes |
|---|---|---|---|
| Singapore | First mover, 2020 | Good Meat chicken, Vow quail, Parima chicken, Aleph Farms beef | Cleared cultivated beef in August 2026, a world first |
| United States | Cleared via joint FDA and USDA review | Upside Foods chicken, Good Meat chicken, Wildtype salmon, Mission Barns pork fat, Believer poultry | Believer shut down in December 2025 despite holding clearance |
| Israel | Approved January 2024 | Aleph Farms Petit Steak | First national approval of cultivated beef |
| Australia and New Zealand | Approved June 2025 | Cultivated quail | Assessed through the joint FSANZ process |
| United Kingdom | Under assessment | None for human food | Pet food applications have moved faster |
| Canada | Submissions under review | None published | No specific labelling category yet exists |
Approval is not the bottleneck
The Believer Meats case is the one to sit with. The company held United States regulatory clearance and closed its doors in December 2025. That sequence is impossible to reconcile with the standard industry narrative, in which regulation is the wall and clearance is the breakthrough.
What actually constrains the sector is cost per kilogram, and the inputs that drive it. Cell culture media — the nutrient broth cells grow in — was historically formulated for pharmaceutical production, where a gram of product can be worth thousands of dollars. Food is the opposite business. Companies have driven media costs down substantially by removing pharmaceutical-grade growth factors and moving to food-grade inputs, but the remaining gap to conventional meat is measured in multiples, not percentages.
The second constraint is bioreactor capacity. There is very little installed stainless-steel fermentation capacity in the world sized for food-volume cell culture, and building it is a capital project on the scale of a small brewery per production line. A company with regulatory approval and no tank has approval and nothing else.
What Canada is actually deciding
Health Canada assesses cultivated meat as a novel food, meaning the question in front of regulators is narrow: is this product safe to eat, and is it nutritionally equivalent to what it replaces. That assessment does not consider climate impact, animal welfare or market readiness.
Two things make the Canadian file more complicated than the safety question alone. The first is labelling. Canada has rules for simulated meat products, developed for plant-based analogues, but no category that fits a product made of actual animal cells that never belonged to an animal. Cultivated meat is neither simulated nor conventionally slaughtered, and the existing vocabulary does not have a slot for it.
The second is that Canadian approval, when it comes, will arrive into a market where the nearest large neighbour has already cleared five products and is watching several of those companies struggle commercially. Regulators reviewing a novel food generally have limited incentive to move quickly on an application whose applicants may not be operating by the time a decision issues.
Where the sector is actually going
Three adjustments are visible in 2026, and all three are retreats from the original pitch.
Ingredients rather than cuts. Mission Barns was cleared for cultivated pork fat, not pork. Fat is where much of meat’s flavour lives, and a small percentage of cultivated fat blended into a plant-based product changes the eating experience without requiring anyone to grow a muscle structure. The economics are far more forgiving.
Premium and novelty categories. Cultivated foie gras, quail and specialty seafood have moved ahead of chicken and beef because they compete against expensive conventional products rather than commodity protein. Matching the price of a supermarket chicken breast is a much harder target than matching foie gras.
Pet food. The regulatory path is shorter, the palatability bar is lower, and the volumes are meaningful. Several companies have pivoted here entirely.
None of this is failure, but it is a different industry from the one that promised to displace industrial animal agriculture within a decade. It looks more like an ingredient business, and it is likely to reach Canadian consumers first as a component of something else rather than as a steak.
Frequently asked questions
Is lab-grown meat approved in Canada?
No. Health Canada has confirmed receiving submissions under the novel foods framework, but no approval has been published as of 2026. There is also no dedicated labelling category for cell-cultured products in Canadian food regulation.
Which countries have approved cultivated meat?
Singapore, the United States, Israel, and Australia and New Zealand have granted clearances. Singapore approved cultivated beef in August 2026, the first jurisdiction to do so. The United Kingdom and Canada have applications under assessment.
Can you buy cultivated meat anywhere right now?
Only in very limited, largely symbolic settings — restaurant tastings and small pilot releases. No cultivated meat product is sold at commercial scale anywhere in the world, despite roughly a dozen approvals.
Why is cultivated meat still expensive?
Two reasons dominate: the cost of cell culture media, which descends from pharmaceutical manufacturing, and the near-absence of food-scale bioreactor capacity. Regulatory clearance addresses neither.
What is the difference between cultivated meat and plant-based meat?
Plant-based products are made from plant proteins engineered to imitate meat. Cultivated meat is grown from actual animal cells in a bioreactor, so it is animal tissue biologically, produced without raising or slaughtering an animal.
When might cultivated meat be sold in Canada?
No timeline has been announced. Industry expectations point to market entry after 2026 at the earliest, and the first Canadian appearance is more likely to be cultivated fat blended into another product than a standalone cut of meat.
